Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 03, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Gentronix Extends Toxicology Screening Services to Apoptosis
Tuesday, August 13, 2013
Company adds apoptosis testing to provide follow-up for micronucleus positive results.

Pace of Designer Drugs Increases Year on Year
Monday, August 12, 2013
Science needs to work hard to keep pace with clandestine designer drugs labs – that was the hard-hitting message delivered to delegates at AACC Clinical Lab Expo.

Agilent Enhances Dissolution Workstation Software
Friday, August 02, 2013
Greater instrument control and improved monitoring of pharmaceutical ingredients.

Hurel Corporation Launches Cell-Based In Vitro Testing Product Suite
Wednesday, July 17, 2013
Suite is milestone in movement away from use of live animals in drug and toxicity testing.

Thermo Fisher Unveils LC-MS Software
Sunday, July 14, 2013
Thermo Fisher's Mass Spectrometry group has updated its software packages to help customers harness the power of its LC-MS instruments.

Plexpress Launches Dedicated Canine ADME-Tox Service
Friday, July 05, 2013
TRACPACK DOG INDUCTION for preclinical drug candidate screening.

New Automated Immunosuppressive Drug Assays from Roche
Tuesday, June 25, 2013
Roche enables immunosuppressive drug assays to be consolidated onto main laboratory automated platforms.

Phenom-World Unveils the Third Generation Phenom Desktop SEM
Tuesday, June 25, 2013
With a magnification range up to 100,000x and resolution of 17nm the Phenom ProX delivers more detailed information than ever before.

Agilent Launches RapidFire 365 High-Throughput Mass Spectrometry System
Tuesday, June 11, 2013
Product provides walkaway mass spectrometric analysis for researchers working on drug discovery, clinical research and forensic toxicology.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 642
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv